COMMUNIQUÉS West-GlobeNewswire

Immunicum AB (publ) Announces Publication of Scientific Review of Ilixadencel Approach in Pharmaceutical Research

18/06/2018 - 14:01

Press Release 18 June 2018 Immunicum AB (publ) Announces Publication of Scientific Review of Ilixadencel Approach in Pharmaceutical Research Immunicum AB (publ; IMMU.ST) announced today the online publication of a [...]

Evolus Expands Management Team with Appointment of Michael Mazen Jafar as Chief Marketing Officer

18/06/2018 - 14:01

Mr. Jafar Joins Evolus from Allergan as the Company Expands its Commercial Infrastructure IRVINE, Calif., June 18, 2018 (GLOBE NEWSWIRE) -- Evolus, Inc. (NASDAQ:EOLS) (“Evolus” or the “Company”), a company dedicated to [...]

Tetra Bio-Pharma Takes on Fentanyl in Head to Head Trial for the Treatment of Breakthrough Pain

18/06/2018 - 14:00

First Clinical Study to Assess Cannabis as an Alternative to Fentanyl ORLEANS, Ontario, June 18, 2018 (GLOBE NEWSWIRE) -- Tetra Bio-Pharma Inc ., a leader in cannabinoid-based drug discovery and development (TSX VENTURE [...]

PolarityTE Provides Corporate Update on Company Progress

18/06/2018 - 14:00

SALT LAKE CITY, June 18, 2018 (GLOBE NEWSWIRE) -- PolarityTE, Inc. (Nasdaq:COOL), a commercial-stage biotechnology and regenerative biomaterials company focused on transforming the lives of patients by discovering, [...]

IBEX Reports Results for the Third Quarter and the Nine Months Ended April 30, 2018

18/06/2018 - 14:00

MONTRÉAL, June 18, 2018 (GLOBE NEWSWIRE) -- IBEX Technologies Inc. (“IBEX” or the “Company”) (TSX Venture:IBT) today reported its financial results for the nine months ended April 30, 2018. “We are pleased to see the [...]

Exalenz Announces Confidential Submission of Draft Registration Statement for Initial Public Offering

18/06/2018 - 14:00

MODI’IN, Israel and MANASQUAN, N.J., June 18, 2018 (GLOBE NEWSWIRE) -- Exalenz Bioscience Ltd. (TASE:EXEN), a leader in developing and marketing non-invasive medical devices for diagnosing and monitoring a range of [...]

Allan R. Mendez, DPT, SCS is Selected to the American Health Council’s Physical Therapy Board

18/06/2018 - 14:00

NEW YORK, June 18, 2018 (GLOBE NEWSWIRE) -- The American Health Council selected Allan R. Mendez, DPT, SCS to its Board of Physical Therapy for his outstanding contributions to improving his patients’ health and well- [...]

Everett Jolly, Host of “Stock Day” Welcomes Richard T. Schumacher of Pressure BioSciences Back on the Show to Discuss Significant Debt to Equity Conversions and other Recent Accomplishments

18/06/2018 - 14:00

PHOENIX, June 18, 2018 (GLOBE NEWSWIRE) -- Richard T. Schumacher, President and CEO of Pressure BioSciences, Inc. (OTCQB:PBIO) (“PBI” and “the Company”) was recently interviewed on Uptick Newswire’s “Stock Day” podcast [...]

Caelum Biosciences Announces Presentation of Complete Cardiac Data Analysis from Phase 1b Trial of CAEL-101 in AL Amyloidosis at American Society of Echocardiography 29th Annual Scientific Sessions

18/06/2018 - 13:30

Columbia University to present data demonstrating CAEL-101 positively impacts myocardial function in patients with AL amyloidosis as measured by global longitudinal strain NEW YORK, June 18, 2018 (GLOBE NEWSWIRE) -- [...]

TG Therapeutics, Inc. Presents Phase 2 Data Evaluating Umbralisib in CLL Patients Intolerant to Prior BTK or PI3K Delta Inhibitor Therapy at the 23rd Congress of the European Hematology Association (EHA)

18/06/2018 - 13:30

NEW YORK, June 18, 2018 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ:TGTX), today announced an oral presentation of clinical data from its ongoing Phase 2 study evaluating umbralisib (TGR-1202), the Company’s PI3K [...]

Eloxx Appoints Global Pharmaceutical Leader, Neil Belloff, Executive Vice President, General Counsel and Corporate Secretary

18/06/2018 - 13:30

WALTHAM, Mass., June 18, 2018 (GLOBE NEWSWIRE) -- Eloxx Pharmaceuticals, Inc. (“Eloxx”) (Nasdaq:ELOX), a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel therapeutics to treat [...]

Ziopharm Oncology Reports on Status of Investigational New Drug Application for Phase 1 Trial to Evaluate CD19-targeted CAR T Therapy

18/06/2018 - 13:30

BOSTON, June 18, 2018 (GLOBE NEWSWIRE) -- Ziopharm Oncology , Inc. (Nasdaq:ZIOP) today announced the U.S. Food and Drug Administration (FDA) placed on clinical hold a Phase 1 trial to evaluate CD19-specific CAR-T [...]

Myriad’s BRACAnalysis CDx® Supplementary PMA Accepted by FDA for Review as a Companion Diagnostic for Talazoparib in Metastatic Breast Cancer

18/06/2018 - 13:05

SALT LAKE CITY, June 18, 2018 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ:MYGN), a leader in molecular diagnostics and personalized medicine, today announced that the U.S. Food and Drug Administration (FDA) has [...]

Helius Medical Technologies, Inc. Provides Update on its Anticipated Submission for FDA Clearance of the PoNS™ Device

18/06/2018 - 13:01

NEWTOWN, Pa., June 18, 2018 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (NASDAQ:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, updated today the expected [...]

ObsEva SA Achieves Primary and Secondary Endpoints for EDELWEISS Phase 2b Clinical Trial of Linzagolix (OBE2109) in Women with Endometriosis

18/06/2018 - 13:00

Partial suppression of estradiol with moderate dose (75mg) of linzagolix demonstrated highly significant reduction of pain and improvement of patient well-being High dose (200mg) of linzagolix achieves full estradiol [...]

Rhythm Pharmaceuticals Announces New Topline Clinical Data from Ongoing Phase 2 Basket Studies Evaluating Setmelanotide in Rare Genetic Disorders of Obesity

18/06/2018 - 13:00

-- Further Improvements Observed in Bardet-Biedl Syndrome Patients; Initial Proof-of-Concept Data in Alström Syndrome Demonstrates Significant Weight Loss and Decreased Hunger -- -- Rhythm Plans to Initiate Combined [...]

Sunesis Pharmaceuticals Announces Presentations at the EHA Annual Meeting

18/06/2018 - 13:00

Université Claude Bernard de Lyon Study Provides Preclinical Validation of Vecabrutinib Activity Against Ibrutinib-Resistant BTK C481S Mutated Lymphomas ERIC Study Shows Half of Ibrutinib-Relapse CLL Patients Carry BTK [...]

The Dementia Discovery Fund and Immuneering announce a Research Collaboration to identify novel drug targets and drug candidates for Alzheimer's disease

18/06/2018 - 13:00

The Dementia Discovery Fund and Immuneering announce a Research Collaboration to identify novel drug targets and drug candidates for Alzheimer's disease Cambridge, MA and London, 18 June 2018 - The Dementia Discovery [...]

Stemline Therapeutics Announces Positive Clinical Data from ELZONRISTM (tagraxofusp; SL-401) Trials in BPDCN, CMML and MF Delivered at the EHA Congress

18/06/2018 - 13:00

NEW YORK, June 18, 2018 (GLOBE NEWSWIRE) -- Stemline Therapeutics, Inc. (Nasdaq:STML), a clinical-stage biopharmaceutical company developing novel oncology therapeutics, announced today that positive clinical data from [...]